title: Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
authors: Giovanni
authors: G
authors: Sotgiu
authors: Christoph
authors: C
authors: Lange
authors: Morgan D'Arcy
authors: MD
authors: Richardson
authors: Alberto
authors: A
authors: Matteelli
authors: Rosella
authors: R
authors: Centis
authors: Barbara
authors: B
authors: Eker
authors: Gunar
authors: G
authors: Guenther
authors: Antonio
authors: A
authors: Spanevello
authors: Giovanni Battista
authors: GB
authors: Migliori
mesh_terms: D000081:Acetamides / Q000008:administration & dosage* / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy; D006801:Humans; D000069349:Linezolid; D023303:Oxazolidinones / Q000008:administration & dosage* / Q000627:therapeutic use*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid